vimarsana.com
Home
Live Updates
Inozyme Pharma To Present Recently Announced Data From Phase 1/2 Trials Of INZ-701 In Adults With ENPP1 Deficiency And ABCC6 Deficiency (PXE) At Upcom... : comparemela.com
Inozyme Pharma To Present Recently Announced Data From Phase 1/2 Trials Of INZ-701 In Adults With ENPP1 Deficiency And ABCC6 Deficiency (PXE) At Upcom...
BOSTON, May 23, 2024 (GLOBE NEWSWIRE) --
Related Keywords
United States ,
France ,
Boston ,
Massachusetts ,
America ,
Pseudoxanthoma Elasticum ,
Stefan Riley ,
Yves Sabbagh ,
Matt Pera ,
Inozyme Pharma ,
Kurt Gunter ,
Endocrine Society Annual Meeting ,
Exchange Commission ,
Facebook ,
European Calcified Tissue Society Congress ,
Corporate Communications ,
Company Or Inozyme ,
Nasdaq ,
Boston Convention Exhibition Center ,
Inozyme Pharma Inc ,
Clinical Public Health ,
Mineral Metabolism Biomarkers ,
Clinical Outcomes ,
Concurrent Oral Presentations ,
Rare Bone ,
Senior Vice President ,
Chief Scientific ,
Exploratory Efficacy ,
Label Study ,
Concurrent Oral Poster Presentations ,
Endocrine Society ,
Annual Meeting ,
Oral Abstract ,
Boston Convention ,
Exhibition Center ,
Chief Medical ,
Trial Design ,
North America ,
Private Securities Litigation Reform Act ,
Annual Report ,
Senior Director ,
comparemela.com © 2020. All Rights Reserved.